FDA Inspection 1003437 — Forbush, Nathan, MD
The FDA completed an inspection of Forbush, Nathan, MD on Feb 24, 2017 in Layton, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 24, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Layton, UT (United States)
Additional Details
Clinical Investigator (CI)